Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03588299 |
|---|---|
| Brief Title: | Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle". |
| First Submitted : | July 6, 2018 |
| First Submitted that Met QC Criteria : | July 6, 2018 |
| First Posted : | July 17, 2018 |
| Last Update Submitted that Met QC Criteria : | February 3, 2023 |
| Last Update Posted : | February 6, 2023 (Estimate) |